pso

🔊🎧 🎙️ What's New in PsO TX: My Real World Experience with Bimekizumab PART 2 🔊🎧

🎙️🩺🔍 Age-defying Dr.Marni Wiseman journeys with us through 22 years in #dermatology, spilling the secrets of revolutionary treatments and today's #psoriasis patient journeys.

🔊🎧 From the evolution of 1st gen biologic therapy to the latest data around Bimekizumab and it's role, we dive into a fresh discussion about Dr.Wiseman's secret sauce when it comes to  treating plaque #psoriasis.

🔊🎧Hear about her initial approach to biologic naïve patients to determine suitability for biologic therapy.

Don't let PART 2 be skin deep; dive right in! 🎙️🩺🔍

In PART 2 we explore: 

•  We deep dive into the real world experience with Dr. Wiseman who brings clarity to the use of Bimekizumab and other molecules in treating moderate to severe plaque psoriasis
• The convenience of Bimekizumab's dosing schedule, its tolerability, and its significant impact on patient-reported outcomes and quality of life. Dr. Wiseman provides a comprehensive view on managing treatment accessibilityand coverage in different Canadian provinces, and  nuances in coverage and criteria for accessing Bimekizumab.
• Dr. Wiseman's approach to baseline workups for patients, emphasizing the importance of screening for comorbidities like psoriatic arthritis and her anticipations for Bimekizumab's expanding indications. She also sheds light on new developments in treating Hidradenitis Suppurativa (HS) with Bimekizumab, based on recent clinical trial data.

 Join us for a masterclass in understanding and managing psoriasis with Dr. Marni Wiseman on the  podcast.

🎙️Spoiler alert: Not all IL-17 inhibitors are created equal! And if you're itching (pun intended) to learn about that one Bimekizumab side effect everyone's talking about and the real world experience, tune in!  

#DermTalks #Derm #MedicineMeetsManagement #BehindTheStethoscope #HealthcareDeepDive #PatientCareFirst #PracticePerfect #SkinAndSystems #DoctorDiaries #ClinicCheckup #HealthcareHacks  #OptimizedOutcomes #DermDeepDive 

Only on the Skin and Joints Podcast !
 

▶️Episode supported by UCB.
 

ABOUT Dr.Marni Wiseman MD FRCPC

Dr. Marni Wiseman began her Dermatology practice in Winnipeg, Manitoba in 2001. In addition to her teaching responsibilities as an Associate Professor and Section Head of Dermatology in the Faculty of Medicine at the University of Manitoba, Dr. Wiseman is the Medical Director of SKiNWISE DERMATOLOGY where she is involved in a general dermatology practice.

Dr. Wiseman’s areas of interest include psoriasis, atopic dermatitis, hidradenitis suppurativa, acne, and aesthetic dermatology. She actively participates in clinical trials through Wiseman Dermatology Research, where she has participated in over a hundred clinical trials. Dr. Wiseman is a frequent supervisor and mentor for medical students and residents. She has extensively published in areas of inflammatory skin disease, photodermatosis, and cutaneous malignancy.

Her community commitments are extensive and include involvement with the Canadian Dermatology Association as Provincial Director of the National Sun Awareness Program. She is an editor of the Journal of Cutaneous Medicine and Surgery, and was the chair of the Skin Cancer Disease Site Group at CancerCare Manitoba for 15 years. Dr. Wiseman does regular outreach skin cancer screening clinics in rural locations of Manitoba, has been featured in many news stories, and regularly presents at meetings and congresses nationally and internationally.

🔊🎧 🎙️ Missing Efficiency in Your Dermatology Clinic: A Dive into Lean Sigma Six with Dr. Perry Grewal PART 2🔊🎧

Dr.Perry Grewal drops in to join us on the Skin and Joints Podcast.

Ever find yourself wading through a sea of paperwork, wondering if your clinic's operations could be mistaken for a confetti cannon explosion? 

Dr.Grewal shares concrete examples from his dermatology practice. Key insights include the need to reduce patient motion, streamline the role of nursing staff, and enhance biopsy organization. 

🎉🙈 This week on 'Clinic Chronicles', we're unpacking the magic of Lean Six Sigma - not just a snazzy buzzword but a transformative approach!

Here's the breakdown: 

1️⃣ Define - No more aimless wandering. Set those clear, crisp goals! 

2️⃣ Measure - Count what counts. Metrics matter, folks! 

3️⃣ Analyze - Spot the bumps and glitches in your clinic matrix. 

4️⃣ Improve - Unleash innovative tweaks that'll make your processes smoother than a latte from your favorite barista. 

 5️⃣ Control - Keep that awesomeness going, like an encore at a rock concert!

We're peeling back the layers of 'business as usual' and diving deep into a system that could have your clinic humming like a well-tuned orchestra. 🎶

So, tune in, and let's streamline your clinic game. And remember, a lean clinic isn’t about dieting—it's about dynamic processes! 💼🚀 #ClinicChronicles #LeanIntoIt

In PART 2 we deep dive:

Areas of Concern in Dermatology Workflow:

1. Motion: Minimizing unnecessary movement – from searching for patient records to walking between rooms.
2. Defects: Reducing errors like wrong medication or missed appointments.
3. Overprocessing: Avoiding repetitive tasks.
4. Transportation: Efficient movement of patients, medications, and equipment.
5. Waiting: Reducing patient and staff wait times.

Beyond these, we chat about the age-old problem of "one more question" from patients, suggesting the use of cheat sheets for frequently asked questions. This episode is a masterclass on evaluating and testing hypotheses in real-world scenarios, with a focus on continuous improvement for enhanced patient care and overall clinic efficiency.

Whether you’re in the field of dermatology or looking to optimize any workflow, this episode offers valuable learnings!

#DermTalks #EfficiencyInHealthcare #PharmacyLife #LeanSigmaSixHealth #DermWorkflow #MedicineMeetsManagement #BehindTheStethoscope #HealthcareDeepDive #PatientCareFirst #PracticePerfect #SkinAndSystems #DoctorDiaries #ClinicCheckup #HealthcareHacks  #PracticeReflections #FromThePharmacyToTheClinic #OptimizedOutcomes #DermDeepDive 

Only on the Skin and Joints Podcast !
 

▶️Episode supported by Novartis.
 

ABOUT Dr. Parbeer S. Grewal MD FRCPC FAAD

Medical Director of Rejuvenation Dermatology and Aesthetics Downtown Edmonton

Associate Clinical Professor, University of Alberta, Division of Dermatology

Dr. Grewal is an Associate Clinical Professor within the Faculty of Medicine, Division of Dermatology, at the University of Alberta. He is the Medical Director of Dermatology and Clinical Research Trials at Rejuvenation Dermatology and Aesthetics Downtown Edmonton. He is also a consulting physician for the University of Alberta Hospital, the Royal Alexandra Hospital, the Grey Nuns Hospital, and the Misericordia Hospital. Dr. Grewal has participated in over 80 clinical research trials and has published many journal articles and book chapters in Dermatology.

🔊🎧 🎙️ What's New in PsO TX: My Real World Experience with Bimekizumab 🔊🎧

🎙️🩺🔍 Age-defying Dr.Marni Wiseman journeys with us through 22 years in #dermatology, spilling the secrets of revolutionary treatments and today's #psoriasis patient journeys.

🔊🎧 From the evolution of 1st gen biologic therapy to the latest data around Bimekizumab and it's role, we dive into a fresh discussion about Dr.Wiseman's secret sauce when it comes to  treating plaque #psoriasis.

🔊🎧Hear about her initial approach to biologic naïve patients to determine suitability for biologic therapy.

Don't let PART 1 be skin deep; dive right in! 🎙️🩺🔍

In PART 1 we explore:

•  Bimekizumab, a new addition to the IL-17 inhibitor family, a humanized IgG1 antibody that binds both IL-17A and IL-17F.
• Clinical trial insights: Significant and clinically meaningful improvements over various comparators in pivotal studies such as BE VIVID, BE READY, BE SURE, and more. We look at efficacy when compared to other biologics like placebo, ustekinumab, adalimumab, and secukinumab
• Does real-world practice experience align with clinical trials?   IL 17 inhibitors, especially bimekizumab, are associated with fungal infections or oral candidiasis: what you need to know about management and if it really is an issue in practice

🎙️Spoiler alert: Not all IL-17 inhibitors are created equal! And if you're itching (pun intended) to learn about that one Bimekizumab side effect everyone's talking about and the real world experience, tune in!  

#DermTalks #Derm #MedicineMeetsManagement #BehindTheStethoscope #HealthcareDeepDive #PatientCareFirst #PracticePerfect #SkinAndSystems #DoctorDiaries #ClinicCheckup #HealthcareHacks  #OptimizedOutcomes #DermDeepDive 

Only on the Skin and Joints Podcast !
 

▶️Episode supported by UCB.
 

ABOUT Dr.Marni Wiseman MD FRCPC

Dr. Marni Wiseman began her Dermatology practice in Winnipeg, Manitoba in 2001. In addition to her teaching responsibilities as an Associate Professor and Section Head of Dermatology in the Faculty of Medicine at the University of Manitoba, Dr. Wiseman is the Medical Director of SKiNWISE DERMATOLOGY where she is involved in a general dermatology practice.

Dr. Wiseman’s areas of interest include psoriasis, atopic dermatitis, hidradenitis suppurativa, acne, and aesthetic dermatology. She actively participates in clinical trials through Wiseman Dermatology Research, where she has participated in over a hundred clinical trials. Dr. Wiseman is a frequent supervisor and mentor for medical students and residents. She has extensively published in areas of inflammatory skin disease, photodermatosis, and cutaneous malignancy.

Her community commitments are extensive and include involvement with the Canadian Dermatology Association as Provincial Director of the National Sun Awareness Program. She is an editor of the Journal of Cutaneous Medicine and Surgery, and was the chair of the Skin Cancer Disease Site Group at CancerCare Manitoba for 15 years. Dr. Wiseman does regular outreach skin cancer screening clinics in rural locations of Manitoba, has been featured in many news stories, and regularly presents at meetings and congresses nationally and internationally.

🎧 BEDTIME STORIES WITH DR.DUTZ.

🎧 "Island Adventures & Lupus Revelations"

🎙️ 🎙️Ever wondered how a tiny island in Singapore shaped its skyline? Or what it's like to bike through a mangrove swamp in the middle of nowhere? How about the breakthroughs in the world of dermatology?

🎧🚴Dive deep into the tropical and historical allure of Singapore's hidden gem, Lau Uben, where city stones tell as Dr. Dutz shares his extraordinary adventures in Singapore's forgotten islands and the latest in dermatological research as we pedal into the intricate world of Lupus and breakthroughs on the horizon. 🚲💉

What's inside:

• Dr. Dutz's thrilling off-the-rail escapade to a lesser-known Singaporean island. 🏝️
• Juicy nuggets from the World Congress: from skin surprises to systemic lupus treatments: what’s new?
• A tease of a revolutionary non-antibody treatment that's turning heads: get the latest buzz on an oral IL-23 inhibitor. Game-changer? 🚀

Plus, you won’t believe which delicious Singaporean experience eluded Dr. Dutz's palate. 

🎧🚀🍜Pack your curiosity (and maybe a snack) - this episode is a rollercoaster of discovery, history, and cutting-edge medicine! 

🌌Tune in. Get enlightened. And maybe a bit of entertainment

#SkinAndJointsPodcast #DrDutzAdventures #SingaporeTales #BedtimeStoriesWithDrDutz

Episode supported by an IME from Pfizer.

🎧 🎉🎙️ Breaking Ground: A Co-Managed Approach to Psoriatic Arthritis - Real World Insights from Dr. Jan Dutz and Dr. Jonathan Chan PART 2

🎙️ Tune in to learn how real-world validated tools can revolutionize psoriatic arthritis management, and the potential for enduring change within the dermatology community in PART 2.

🎧 🎉The discussion takes a significant turn as we delve into the complexities that emerge in treatment strategies, especially in the gap between patient referrals and confirmations of diagnosis. The challenge of masking symptoms and determining the right treatment pathway is examined, stressing the importance of understanding both skin and joint conditions in these patients.

🧵Join us for a dive with eminent psoriatic arthritis experts, Dr. Jan Dutz and Dr. Jonathan Chan. Their unique real-world model of care has caught the attention of our listeners, and in this episode, we finally unravel the inner workings of their combined dermatology and rheumatology clinic.

🫳After countless requests, we've garnered insights into how they run their clinic, how they manage their team, and if this model is sustainable? But that's not all.

🛎️Our dynamic derm-rheum tag team outline compare the practical utility of three different screening tools, in over 50 dermatologists' offices nationwide. Before participating in the project, some dermatologists expressed reservations regarding the perceived time-consuming nature of these tools, the potential for low yield in their population, and a general lack of habitual use or reminders.

• Is this model scalable? What potential barriers stand in its way?  
• And we delve into the intricacies of PSA screening tools – where's the optimal place for deployment? Where can they make the most impact?

🎙️🎙️Looking Forward: A critical question remains whether this change is short-term or will translate into long-term behavioral change?

Warm up those ear phones for PART 2! 

Exclusive to the Skin and Joints Podcast.

Episode supported by Novartis.

🎧 🎉🎙️ Breaking Ground: A Co-Managed Approach to Psoriatic Arthritis - Real World Insights from Dr. Jan Dutz and Dr. Jonathan Chan PART 1

🎧 🎉We're excited to bring you a first-hand look at a unique model of care that's transforming the lives of psoriatic arthritis patients.

🧵Join us for a dive with eminent psoriatic arthritis experts, Dr. Jan Dutz and Dr. Jonathan Chan. Their unique real-world model of care has caught the attention of our listeners, and in this episode, we finally unravel the inner workings of their combined dermatology and rheumatology clinic.

🫳After countless requests, we've garnered insights into how they run their clinic, how they manage their team, and if this model is sustainable? But that's not all.

🛎️Be the first to hear the exclusive findings from a trailblazing real world study that the collaboration of over 50 dermatologists. The focus?  The real world use of PsA screening tools and the early detection of psoriatic arthritis that has the potential to revolutionize psoriatic arthritis detection in clinic.

🛎️This episode is an extension of our conversation with Dr. Dutz from last year, where he unveiled the concept of their model and discussed the validated tools used within their practice. Now, they've turned concept into reality, and we're here to unpack it all.

• Is this model scalable? What potential barriers stand in its way?  
• And we delve into the intricacies of PSA screening tools – where's the optimal place for deployment? Where can they make the most impact?

🎙️🎙️This episode is more than just a conversation - it's a paradigm shift in the treatment of psoriatic disease and psoriatic arthritis.  

🎙️🎙️Get ready for a world-exclusive reveal as we break the results of this ground-breaking real world study right here on our podcast for the first time.

Episode supported by Novartis.

🔊🎧 BRACE YOUR EARS FOR #ROUND 2 🎧🔊

💡💼🌐 We're thrilled to announce the Skin and Joints Podcast back on the airwaves this week with dynamic #dermatology duo, Dr.Melinda Gooderham and Dr.Geeta Yadav for round 2! 🩺

🌊💡Join us as we sail the "#Psoriasis Sea" as we navigate what you need to know #roflumilast's long-term performance.

🎧Not only are we dropping anchor to delve into what you need to know about its #side effects, but we're also setting up the lighthouse to guide you through their manageability

🧑‍🦱🧭We've got the lifeboat you need: our experts will peel back the layers and offer insights into the #topical cream's effectiveness in #plaquePsO #skin #clearance and #itch #reduction. So, if you've been scratching your head 🧑‍🦱 over #psoriasis, it's time to stop!

𝙀𝙫𝙤𝙡𝙪𝙩𝙞𝙤𝙣? 𝙊𝙧 𝙥𝙤𝙨𝙨𝙞𝙗𝙡𝙮 #𝙧𝙚𝙫𝙤𝙡𝙪𝙩𝙞𝙤𝙣 𝙞𝙣 the way we treat #𝙋𝙨𝙤𝙧𝙞𝙖𝙨𝙞𝙨?

🧐🔬🦠 Dr.Geeta Yadav and Dr. Melinda Gooderham are 𝘀𝗼𝗼𝗻 𝗴𝗼𝗶𝗻𝗴 𝘁𝗼 𝘀𝗽𝗶𝗹𝗹 𝘁𝗵𝗲 𝗯𝗲𝗮𝗻𝘀  𝗼𝗻 𝘄𝗵𝗲𝗿𝗲 𝘁𝗵𝗲𝘆 𝘀𝗲𝗲 𝘁𝗵𝗶𝘀 𝗻𝗲𝘄 𝘁𝗵𝗲𝗿𝗮𝗽𝘆'𝘀 𝗽𝗼𝘁𝗲𝗻𝘁𝗶𝗮𝗹 𝗶𝗻 𝗺𝗮𝗸𝗶𝗻𝗴 𝗮 𝗱𝗶𝗳𝗳𝗲𝗿𝗲𝗻𝗰𝗲 𝗳𝗼𝗿 𝗼𝘂𝗿 #𝗽𝗹𝗮𝗾𝘂𝗲𝗣𝘀𝗢 𝗽𝗮𝘁𝗶𝗲𝗻𝘁𝘀

⛵🧭Get ready to set sail with us. This is a conversation that's more than just skin-deep! 🗓️👂

#SkinAndJointsPodcast #Dermatology #Psoriasis #Roflumilast #Healthcare #StayTuned #Podcast #Medicine #SkinHealth #PSO #PDE4inhibitor #innovationmatters


Only on the Skin and Joints Podcast !

 

ABOUT Dr.Melinda Gooderham, MD, FRCPC ( Dermatology)

Toronto, ON

Melinda Gooderham MD MSc FRCPC Dr. Gooderham is a Dermatologist and Medical Director at the SKiN Centre for Dermatology and an Investigator with Probity Medical Research. She is an Assistant Professor at Queens University and a Consultant Physician at the Peterborough Regional Health Centre. She is a fellow of the Royal College of Physicians and Surgeons of Canada.

Dr. Gooderham has been the principal investigator for over 200 clinical trials and she practices with a focus on inflammatory diseases of the skin. She also contributes to several peer-reviewed dermatology publications as an associate editor, reviewer, and has been an author of 205 articles. She enjoys lecturing to global audiences on new therapies for skin diseases.

ABOUT Dr. Geeta Yadav, MSc, MD, FRCPC ( Dermatology)

Toronto, ON

Dr. Geeta Yadav is an expert in both medical and cosmetic dermatology and founder of FACET Dermatology in Toronto. . A second-generation Canadian, her interest in under-serviced communities and treating BIPOC patients was inspired by her childhood travels to India. She holds a master’s degree in International Health from Johns Hopkins and completed her dermatology training at the University of Toronto, where she still teaches today. Dr. Yadav is a fellow of the Royal College of Physicians and Surgeons, the American Academy of Dermatology, and the European Academy of Dermatology and Venereology. She has a special interest in skin of color and has been quoted in numerous main stream publications including the New York Times, Wall Street Journal, Allure, Vanity Fair and Cosmopolitan.

When she’s not working, she volunteers as an Alumni Governor at the University of Toronto. She also loves running, dancing, and spending time with her husband and three young children. 

▶️Episode supported by Arcutis.

🎧 🎉TYK-TOK we’re ready to rock PART 2!

🎙️🎙️ The Skin and Joints Podcast Team continues the conversation with dermatologist dynamic duo Dr.Chih-Ho Hong and Dr.Irina Turchin who respectively lend their real world perspectives on a brand new oral therapy for our patients with moderate to severe psoriasis.

 🛎️ Deucravacitinib is finally here! And we're going to be looking at fresh new data that could change your clinical practice.  We also break it down with our expert Faculty so you don't need to :) 

🧵Where do our experts see the overall place  deucravacitinib in the therapeutic treatment pathway for moderate to severe psoriasis in the real world?

🧵How does it compare with other biologics and non-biologic treatments?

🫳 How effective is it for patients specifically with moderate to severe scalp, nail and palmoplantar psoriasis? 

Episode Learning Objectives

• Describe the overall place of deucravacitinib in the therapeutic treatment pathway for moderate to severe psoriasis in the real world
• Examine the clinical efficacy associated with deucravacitinib and other select  biologic and nonbiologic treatments in patients with moderate to severe PsO
• Explore the correlations between responses on clinical and patient reported outcome (PRO) measures from  pooled data from POETYK PSO-1 and PSO-2 pivotal trials
• Evaluate the efficacy of deucravacitinib treatment in patients with moderate to severe scalp, nail, and palmoplantar psoriasis  subgroup analyses pooled PSO-1 and PSO-2 data 

🎧 🎉TYK-TOK we’re ready to rock.

🎙️🎙️ The Skin and Joints Podcast Team is starting 2023  off strong with dermatologist dynamic duo Dr.Chih-Ho Hong and Dr.Irina Turchin who respectively lend their real world perspectives on a brand new oral therapy for our patients with moderate to severe psoriasis.

🛎️ Deucravacitinib is finally here! And we're going to be looking at. some fresh new data that could change your clinical practice. 

🧵How does it compare with other biologics and non-biologic treatments?

🫳 How effective is it for patients specifically with moderate to severe scalp, nail and palmoplantar psoriasis? 

Episode Learning Objectives

• Apply current evidence as well as shared decision-making to individualize therapy decisions for patients with moderate to severe plaque psoriasis; specifically  deucravacitinib, a novel oral TYK2  inhibitor (PART 1)
• Examine key real world considerations between TYK2 inhibitors with JAK inhibitors in terms of safety and tolerability  (PART 1)
• Explore the correlations between responses on clinical and PRO measures in pooled data from POETYK PSO-1 and PSO-2 (PART 2)
• Evaluate the efficacy of deucravacitinib treatment in patients with moderate to severe scalp, nail, and palmoplantar psoriasis  subgroup analyses pooled PSO-1 and PSO-2 data  (PART 2)

Episode supported by an IME Grant from BMS.  

💡💡💡 𝐃𝐫.𝐘𝐚𝐝𝐚𝐯 𝐚𝐧𝐝 𝐃𝐫.𝐉𝐨𝐬𝐞𝐩𝐡 𝐥𝐨𝐨𝐤 𝐭𝐨 𝐬𝐞𝐭𝐭𝐥𝐞 𝐭𝐡𝐞 𝐝𝐞𝐛𝐚𝐭𝐞 𝐢𝐧 𝐏𝐀𝐑𝐓 𝐈𝐈 𝐨𝐟 𝑰𝑻 𝑻𝑨𝑲𝑬𝑺 2 𝑻𝑶 𝑻𝒀𝑲 2.

🟢𝐇𝐚𝐯𝐞 𝐲𝐨𝐮 𝐛𝐞𝐞𝐧 𝐰𝐨𝐧𝐝𝐞𝐫𝐢𝐧𝐠 𝐰𝐡𝐚𝐭'𝐬 𝐭𝐡𝐞 𝐫𝐞𝐚𝐥 𝐝𝐢𝐟𝐟𝐞𝐫𝐞𝐧𝐜𝐞 𝐛𝐞𝐭𝐰𝐞𝐞𝐧 #𝐉𝐀𝐊 𝐢𝐧𝐡𝐢𝐛𝐢𝐭𝐢𝐨𝐧 𝐚𝐧𝐝 #𝐓𝐘𝐊-𝟐 𝐢𝐧𝐡𝐢𝐛𝐢𝐭𝐢𝐨𝐧? 𝐀𝐫𝐞𝐧'𝐭 𝐭𝐡𝐞𝐲 𝐩𝐚𝐫𝐭 𝐨𝐟 𝐭𝐡𝐞 𝐬𝐚𝐦𝐞 𝐩𝐚𝐭𝐡𝐰𝐚𝐲?  

𝗪𝗲𝗹𝗹 𝘄𝗲 𝘁𝗮𝗸𝗲 𝗮 𝗱𝗲𝗲𝗽 𝗱𝗶𝘃𝗲 𝗶𝗻𝘁𝗼 𝘁𝗵𝗲 𝘀𝗮𝗳𝗲𝘁𝘆 𝗰𝗼𝗻𝘃𝗲𝗿𝘀𝗮𝘁𝗶𝗼𝗻 𝗮𝗻𝗱 seek clarify for you when it comes to all you need to know about key 𝗧𝗬𝗞 𝘃𝘀 𝗝𝗔𝗞 𝘀𝗶𝗱𝗲 𝗲𝗳𝗳𝗲𝗰𝘁 𝗮𝗻𝗱 𝗺𝗼𝗻𝗶𝘁𝗼𝗿𝗶𝗻𝗴 𝗰𝗼𝗻𝘀𝗶𝗱𝗲𝗿𝗮𝘁𝗶𝗼𝗻𝘀.

Our experts 𝗮𝗹𝘀𝗼 𝗯𝗿𝗲𝗮𝗸𝗱𝗼𝘄𝗻  𝗣𝗢𝗘𝗧𝗬𝗞-𝟭 𝗮𝗻𝗱 𝗣𝗢𝗘𝗧𝗬𝗞-𝟮 𝗮𝗻𝗱 𝘀𝗵𝗮𝗿𝗲 𝘁𝗵𝗲𝗶𝗿 𝗰𝗮𝗻𝗱𝗶𝗱 𝘁𝗵𝗼𝘂𝗴𝗵𝘁𝘀 𝗼𝗻 𝘄𝗵𝗲𝗿𝗲 𝘁𝗵𝗲𝘆 𝘀𝗲𝗲 𝘁𝗵𝗲 𝗽𝗹𝗮𝗰𝗲 𝗼𝗳 𝗮 𝗧𝗬𝗞-𝟮 𝗶𝗻𝗵𝗶𝗯𝗶𝘁𝗼𝗿, 𝗶𝗻 𝘁𝗵𝗲𝗶𝗿 𝗽𝗿𝗮𝗰𝘁𝗶𝗰𝗲𝘀, 𝗳𝗼𝗿 𝘁𝗵𝗲 𝘁𝗿𝗲𝗮𝘁𝗺𝗲𝗻𝘁 𝗼𝗳 𝗺𝗼𝗱𝗲𝗿𝗮𝘁𝗲 𝘁𝗼 𝘀𝗲𝘃𝗲𝗿𝗲 𝗽𝘀𝗼𝗿𝗶𝗮𝘀𝗶𝘀.

🟢𝘼𝙧𝙚 𝙩𝙝𝙚𝙧𝙚 𝙖𝙣𝙮 𝙥𝙧𝙖𝙘𝙩𝙞𝙘𝙖𝙡 𝙘𝙤𝙣𝙨𝙞𝙙𝙚𝙧𝙖𝙩𝙞𝙤𝙣𝙨 𝙛𝙤𝙧 𝙥𝙖𝙩𝙞𝙚𝙣𝙩𝙨 𝙬𝙝𝙤 𝙖𝙧𝙚  𝙗𝙞𝙤𝙡𝙤𝙜𝙞𝙘 𝙣𝙖ï𝙫𝙚  𝙫𝙚𝙧𝙨𝙪𝙨 𝙗𝙞𝙤 𝙚𝙭𝙥𝙚𝙧𝙞𝙚𝙣𝙘𝙚𝙙?

🟢What 𝐝𝐨𝐞𝐬 #TYK-2 #inhibition mean for 𝐭𝐡𝐞 #𝐩𝐬𝐨𝐫𝐢𝐚𝐬𝐢𝐬 𝐩𝐚𝐭𝐢𝐞𝐧𝐭 treatment landscape?

🟢And when do I recommend an i𝐧𝐣𝐞𝐜𝐭𝐚𝐛𝐥𝐞 𝐯𝐞𝐫𝐬𝐮𝐬 𝐨𝐫𝐚𝐥 therapy 𝐟𝐨𝐫 𝐦𝐲 𝐩𝐚𝐭𝐢𝐞𝐧𝐭?

🎫 𝗧𝗵𝗶𝘀 𝗺𝗮𝗿𝗸𝘀 𝗮 𝗳𝗶𝗿𝘀𝘁 𝗳𝗼𝗿 𝘁𝗵𝗲 𝗦𝗸𝗶𝗻 𝗮𝗻𝗱 𝗝𝗼𝗶𝗻𝘁𝘀 𝗣𝗼𝗱𝗰𝗮𝘀𝘁- 𝘄𝗲 𝗵𝗮𝘃𝗲 𝘁𝘄𝗼 𝗴𝘂𝗲𝘀𝘁 𝗲𝘅𝗽𝗲𝗿𝘁𝘀 𝗼𝗻 𝘁𝗵𝗲 𝘀𝗵𝗼𝘄 𝗮𝘁 𝘁𝗵𝗲 𝘀𝗮𝗺𝗲 𝘁𝗶𝗺𝗲!

𝗪𝗲 𝗮𝗿𝗲 𝗴𝗼𝗶𝗻𝗴 𝘁𝗼 𝗹𝗼𝗼𝗸 𝗮𝘁 𝗧𝗬𝗞𝟮 𝗶𝗻𝗵𝗶𝗯𝗶𝘁𝗶𝗼𝗻, 𝗮𝗻𝗱 𝗶𝘁’𝘀 𝗿𝗼𝗹𝗲 𝗶𝗻 𝘁𝗵𝗲 𝗽𝘀𝗼𝗿𝗶𝗮𝘀𝗶𝘀 𝘁𝗿𝗲𝗮𝘁𝗺𝗲𝗻𝘁 𝗹𝗮𝗻𝗱𝘀𝗰𝗮𝗽𝗲 𝘄𝗶𝘁𝗵 𝗮 𝗳𝗼𝗰𝘂𝘀 𝗼𝗻 𝗮 𝗻𝗲𝘄 𝗼𝗿𝗮𝗹 𝘀𝗲𝗹𝗲𝗰𝘁𝗶𝘃𝗲 𝗧𝗬𝗞𝟮 𝗶𝗻𝗵𝗶𝗯𝗶𝘁𝗼𝗿 𝗮𝗴𝗲𝗻𝘁 𝗰𝗮𝗹𝗹𝗲𝗱 𝗱𝗲𝘂𝗰𝗿𝗮𝘃𝗮𝗰𝗶𝘁𝗶𝗻𝗶𝗯 𝗮𝗻𝗱 𝘄𝗵𝗮𝘁 𝘁𝗵𝗶𝘀 𝘀𝗲𝗹𝗲𝗰𝘁𝗶𝘃𝗲𝗹𝘆 𝗰𝗼𝗻𝗳𝗲𝗿𝘀 𝗳𝗿𝗼𝗺 𝗮 𝘀𝗮𝗳𝗲𝘁𝘆 𝗽𝗿𝗼𝗳𝗶𝗹𝗲.

𝗗𝗼𝗲𝘀 𝗶𝘁 𝗧𝗬𝗞 𝗮𝗹𝗹 𝘁𝗵𝗲 𝗯𝗼𝘅𝗲𝘀? 𝗟𝗲𝘁’𝘀 𝗳𝗶𝗻𝗱 𝗼𝘂𝘁!

🎙️🎙️🎙️ 𝐏𝐚𝐫𝐭 II with Dr.Geeta Yadav and Dr.Marissa Joseph!

Episode Learning Objectives

• ​​Apply current evidence to key efficacy and safety considerations for the oral, selective allosteric tyrosine kinase 2 (TYK2) inhibitor deucravacitinib 
•  Describe the  summary details and potential clinical implications of the  pivotal trials POETYK-1 and POETYK-2 
• Discuss the role of TYK-2 inhibition in moderate to severe psoriasis and the patient journey

ABOUT Dr. Marissa Joseph, MSc, MD, FRCPC ( Pediatrics), FRCPC ( Dermatology)

Toronto, ON

Dr. Marissa Joseph is a board certified Pediatrician and Dermatologist and completed her Pediatric training at the Hospital For Sick Children, followed by her Dermatology residency at the University of Toronto. She completed a MSc in Community Health at the Dalla Lana School of Public Health.

Dr. Joseph is full time academic faculty at the University of Toronto. She has received and has been nominated for teaching awards in both undergraduate and postgraduate medical education. 

Dr. Joseph is the Medical Director of the Ricky Kanee Schachter Dermatology Centre at Women's College Hospital. She also works at the Hospital For Sick Children where she manages children with complex dermatologic disease in outpatient and inpatient settings, as well as a pediatric laser treatment program. Dr. Joseph enjoys her diverse practice in general adult, pediatric and surgical dermatology. Her clinical and research interests include inflammatory skin disorders such as psoriasis, atopic dermatitis, and hidradenitis suppurativa; genodermatoses, and equity, diversity and inclusivity.

ABOUT Dr. Geeta Yadav, MSc, MD, FRCPC ( Pediatrics), FRCPC ( Dermatology)

Toronto, ON

Dr. Geeta Yadav is an expert in both medical and cosmetic dermatology. A second-generation Canadian, her interest in under-serviced communities and treating BIPOC patients was inspired by her childhood travels to India. She holds a master’s degree in International Health from Johns Hopkins and completed her dermatology training at the University of Toronto, where she still teaches today. Dr. Yadav is a fellow of the Royal College of Physicians and Surgeons, the American Academy of Dermatology, and the European Academy of Dermatology and Venereology. 

When she’s not working, she volunteers as an Alumni Governor at the University of Toronto. She also loves running, dancing, and spending time with her husband and three young children. 

▶️Episode supported by an IME Grant from Bristol Myers Squibb

💡💡💡𝐇𝐚𝐯𝐞 𝐲𝐨𝐮 𝐛𝐞𝐞𝐧 𝐰𝐨𝐧𝐝𝐞𝐫𝐢𝐧𝐠 𝐰𝐡𝐚𝐭'𝐬 𝐭𝐡𝐞 𝐫𝐞𝐚𝐥 𝐝𝐢𝐟𝐟𝐞𝐫𝐞𝐧𝐜𝐞 𝐛𝐞𝐭𝐰𝐞𝐞𝐧 #𝐉𝐀𝐊 𝐢𝐧𝐡𝐢𝐛𝐢𝐭𝐢𝐨𝐧 𝐚𝐧𝐝 #𝐓𝐘𝐊-𝟐 𝐢𝐧𝐡𝐢𝐛𝐢𝐭𝐢𝐨𝐧? 𝐀𝐫𝐞𝐧'𝐭 𝐭𝐡𝐞𝐲 𝐩𝐚𝐫𝐭 𝐨𝐟 𝐭𝐡𝐞 𝐬𝐚𝐦𝐞 𝐩𝐚𝐭𝐡𝐰𝐚𝐲?

🟢What 𝐝𝐨𝐞𝐬 #TYK-2 #inhibition mean for 𝐭𝐡𝐞 #𝐩𝐬𝐨𝐫𝐢𝐚𝐬𝐢𝐬 𝐩𝐚𝐭𝐢𝐞𝐧𝐭 treatment landscape?

🟢And when do I recommend an i𝐧𝐣𝐞𝐜𝐭𝐚𝐛𝐥𝐞 𝐯𝐞𝐫𝐬𝐮𝐬 𝐨𝐫𝐚𝐥 therapy 𝐟𝐨𝐫 𝐦𝐲 𝐩𝐚𝐭𝐢𝐞𝐧𝐭?

🎫 𝗧𝗵𝗶𝘀 𝗺𝗮𝗿𝗸𝘀 𝗮 𝗳𝗶𝗿𝘀𝘁 𝗳𝗼𝗿 𝘁𝗵𝗲 𝗦𝗸𝗶𝗻 𝗮𝗻𝗱 𝗝𝗼𝗶𝗻𝘁𝘀 𝗣𝗼𝗱𝗰𝗮𝘀𝘁- 𝘄𝗲 𝗵𝗮𝘃𝗲 𝘁𝘄𝗼 𝗴𝘂𝗲𝘀𝘁 𝗲𝘅𝗽𝗲𝗿𝘁𝘀 𝗼𝗻 𝘁𝗵𝗲 𝘀𝗵𝗼𝘄 𝗮𝘁 𝘁𝗵𝗲 𝘀𝗮𝗺𝗲 𝘁𝗶𝗺𝗲!

𝗪𝗲 𝗮𝗿𝗲 𝗴𝗼𝗶𝗻𝗴 𝘁𝗼 𝗹𝗼𝗼𝗸 𝗮𝘁 𝗧𝗬𝗞𝟮 𝗶𝗻𝗵𝗶𝗯𝗶𝘁𝗶𝗼𝗻, 𝗮𝗻𝗱 𝗶𝘁’𝘀 𝗿𝗼𝗹𝗲 𝗶𝗻 𝘁𝗵𝗲 𝗽𝘀𝗼𝗿𝗶𝗮𝘀𝗶𝘀 𝘁𝗿𝗲𝗮𝘁𝗺𝗲𝗻𝘁 𝗹𝗮𝗻𝗱𝘀𝗰𝗮𝗽𝗲 𝘄𝗶𝘁𝗵 𝗮 𝗳𝗼𝗰𝘂𝘀 𝗼𝗻 𝗮 𝗻𝗲𝘄 𝗼𝗿𝗮𝗹 𝘀𝗲𝗹𝗲𝗰𝘁𝗶𝘃𝗲 𝗧𝗬𝗞𝟮 𝗶𝗻𝗵𝗶𝗯𝗶𝘁𝗼𝗿 𝗮𝗴𝗲𝗻𝘁 𝗰𝗮𝗹𝗹𝗲𝗱 𝗱𝗲𝘂𝗰𝗿𝗮𝘃𝗮𝗰𝗶𝘁𝗶𝗻𝗶𝗯 𝗮𝗻𝗱 𝘄𝗵𝗮𝘁 𝘁𝗵𝗶𝘀 𝘀𝗲𝗹𝗲𝗰𝘁𝗶𝘃𝗲𝗹𝘆 𝗰𝗼𝗻𝗳𝗲𝗿𝘀 𝗳𝗿𝗼𝗺 𝗮 𝘀𝗮𝗳𝗲𝘁𝘆 𝗽𝗿𝗼𝗳𝗶𝗹𝗲.

𝗗𝗼𝗲𝘀 𝗶𝘁 𝗧𝗬𝗞 𝗮𝗹𝗹 𝘁𝗵𝗲 𝗯𝗼𝘅𝗲𝘀? 𝗟𝗲𝘁’𝘀 𝗳𝗶𝗻𝗱 𝗼𝘂𝘁!

🎙️🎙️🎙️ 𝐏𝐚𝐫𝐭 𝐈  with Dr.Geeta Yadav and Dr.Marissa Joseph!

Episode Learning Objectives

• Discuss patient unmet needs  as well as appropriate assessment strategies to guide treatment decisions for  moderate to severe psoriasis 
• ​​Apply current evidence as well as shared decision-making to individualize oral and injectable therapy decisions for patients with moderate to severe plaque psoriasis 
•  Describe the role and pathophysiology of TYK-2 (tyrosine kinase 2)  inhibition in the clinical manifestation of psoriasis

ABOUT Dr. Marissa Joseph, MSc, MD, FRCPC ( Pediatrics), FRCPC ( Dermatology)

Toronto, ON

Dr. Marissa Joseph is a board certified Pediatrician and Dermatologist and completed her Pediatric training at the Hospital For Sick Children, followed by her Dermatology residency at the University of Toronto. She completed a MSc in Community Health at the Dalla Lana School of Public Health.

Dr. Joseph is full time academic faculty at the University of Toronto. She has received and has been nominated for teaching awards in both undergraduate and postgraduate medical education. 

Dr. Joseph is the Medical Director of the Ricky Kanee Schachter Dermatology Centre at Women's College Hospital. She also works at the Hospital For Sick Children where she manages children with complex dermatologic disease in outpatient and inpatient settings, as well as a pediatric laser treatment program. Dr. Joseph enjoys her diverse practice in general adult, pediatric and surgical dermatology. Her clinical and research interests include inflammatory skin disorders such as psoriasis, atopic dermatitis, and hidradenitis suppurativa; genodermatoses, and equity, diversity and inclusivity.

ABOUT Dr. Geeta Yadav, MSc, MD, FRCPC ( Pediatrics), FRCPC ( Dermatology)

Toronto, ON

Dr. Geeta Yadav is an expert in both medical and cosmetic dermatology. A second-generation Canadian, her interest in under-serviced communities and treating BIPOC patients was inspired by her childhood travels to India. She holds a master’s degree in International Health from Johns Hopkins and completed her dermatology training at the University of Toronto, where she still teaches today. Dr. Yadav is a fellow of the Royal College of Physicians and Surgeons, the American Academy of Dermatology, and the European Academy of Dermatology and Venereology. 

When she’s not working, she volunteers as an Alumni Governor at the University of Toronto. She also loves running, dancing, and spending time with her husband and three young children. 

▶️Episode supported by an IME Grant from Bristol Myers Squibb

We sit down with Vancouver-based dermatologist and Skin and Joints Podcast Faculty, Dr.Angela Law,  to explore the role of topical formulation design and the impact it can have in  the management of mild to moderate plaque psoriasis.  

Can a change in vehicle result in a change in efficacy and safety?  Dr.Law delivers a masterclass-ie we take a comparative  deep dive look into new data on calcipotriol/betamethasone dipropionate topical formulations in psoriasis.  

Dr.Law also drops her clinical treatment secrets when it comes to optimizing her patient's psoriasis that you do not want to miss.  

So should you reach for that gel, foam or ointment? Let's find out!

You'll also hear the (soothing) voice of Dermatology Resident Co-Host  Touraj Khosravi for the first time.  

About Dr.Angela Law, MD, FRCPC  

Dermatologist  | Vancouver

Dr.Angela Law is a dually certified dermatologist in Canada and the US. She completed her medical school training at the University of British Columbia and was accepted into the joint Dermatology program between the University of Saskatchewan and Dalhousie University. She opened SkinSense Dermatology in Saskatoon after residency and practiced medical and aesthetic dermatology for six years before moving back to Vancouver during the COVID pandemic.  

She is a Clinical Instructor in the Department of Dermatology and Skin Sciences at UBC and sits on the Undergraduate Education Committee in Dermatology. She has a special interest in pediatric and adolescent dermatology but has been trained in all aspects of medical, surgical and cosmetic dermatology. She splits her time between her new medical clinic with a group of seasoned plastic surgeons at Clinic One Three Eight in downtown Vancouver, aesthetics at Dermapure and a Dermatology rapid access clinic at Mount St. Joseph’s Hospital through Providence Health. 

Episode supported by an independent grant from LEO Pharma.

📻www.skinandjoints.ca

✉️info@skinandjoints.ca

🎙️🎙️ 📭 𝐓𝐡𝐞 𝐩𝐞𝐨𝐩𝐥𝐞 𝐡𝐚𝐯𝐞 𝐬𝐩𝐨𝐤𝐞𝐧, 𝐚𝐧𝐝 𝐬𝐨 𝐰𝐞 𝐡𝐚𝐝 𝐭𝐨 𝐥𝐢𝐬𝐭𝐞𝐧. 𝐀 𝐟𝐢𝐫𝐬𝐭 𝐨𝐟 𝐬𝐨𝐫𝐭𝐬 𝐟𝐨𝐫 𝐭𝐡𝐞 Skin and Joints Podcast, 𝐃𝐫.𝐉𝐚𝐠𝐠𝐢 𝐑𝐚𝐨 𝐛𝐞𝐜𝐨𝐦𝐞𝐬 𝐭𝐡𝐞 𝐟𝐢𝐫𝐬𝐭 𝐫𝐞𝐭𝐮𝐫𝐧𝐢𝐧𝐠 Faculty 𝐞𝐱𝐩𝐞𝐫𝐭 𝐨𝐧 𝐭𝐡𝐞 𝐏𝐨𝐝𝐜𝐚𝐬𝐭! (𝑾𝒆 𝒕𝒉𝒊𝒏𝒌 𝒊𝒕'𝒔 𝒃𝒆𝒄𝒂𝒖𝒔𝒆 𝒐𝒇 𝒉𝒊𝒔 𝒔𝒐𝒐𝒕𝒉𝒊𝒏𝒈 𝒓𝒂𝒅𝒊𝒐 𝒗𝒐𝒊𝒄𝒆).

🌐 🌐 𝐇𝐚𝐯𝐞 𝐲𝐨𝐮 𝐡𝐞𝐚𝐫𝐝 𝐨𝐟 𝐇𝐎𝐑𝐈𝐙𝐎𝐍?  

𝐃𝐫.𝐑𝐚𝐨 𝐠𝐮𝐢𝐝𝐞𝐬 𝐮𝐬 𝐭𝐡𝐫𝐨𝐮𝐠𝐡 𝐚 𝐧𝐨𝐯𝐞𝐥 𝐜𝐨𝐧𝐬𝐞𝐧𝐬𝐮𝐬 𝐩𝐫𝐨𝐭𝐨𝐜𝐨𝐥 𝐨𝐧 𝐭𝐡𝐞 #𝐛𝐢𝐨𝐥𝐨𝐠𝐢𝐜 𝐦𝐚𝐧𝐚𝐠𝐞𝐦𝐞𝐧𝐭 𝐚𝐧𝐝 𝐭𝐫𝐞𝐚𝐭𝐦𝐞𝐧𝐭 𝐨𝐟 𝐦𝐨𝐝𝐞𝐫𝐚𝐭𝐞-𝐭𝐨-𝐬𝐞𝐯𝐞𝐫𝐞 #𝐩𝐬𝐨𝐫𝐢𝐚𝐬𝐢𝐬 𝐚𝐜𝐡𝐢𝐞𝐯𝐞𝐝 𝐛𝐲 𝐚 𝐩𝐚𝐧𝐞𝐥 𝐨𝐟 39 leading 𝐂𝐚𝐧𝐚𝐝𝐢𝐚𝐧 #𝐝𝐞𝐫𝐦𝐚𝐭𝐨𝐥𝐨𝐠𝐢𝐬𝐭𝐬

🔑🔑💡 𝗪𝗵𝗮𝘁 𝗹𝗮𝘁𝗲𝘀𝘁 #𝘁𝗿𝗲𝗮𝘁𝗺𝗲𝗻𝘁 𝗼𝗽𝘁𝗶𝗼𝗻𝘀 𝗰𝗮𝗺𝗲 𝗼𝘂𝘁 𝗼𝗻 𝘁𝗼𝗽 𝗳𝗼𝗿 𝗣𝘀𝗢 +/- 𝘄𝗶𝘁𝗵 𝗻𝗮𝗶𝗹 𝘃𝘀 𝘀𝗰𝗮𝗹𝗽 𝘃𝘀 #𝗽𝗮𝗹𝗺𝗼𝗽𝗹𝗮𝗻𝘁𝗮𝗿 𝗶𝗻𝘃𝗼𝗹𝘃𝗲𝗺𝗲𝗻𝘁? 𝗪𝗵𝗮𝘁 𝘁𝗿𝗲𝗮𝘁𝗺𝗲𝗻𝘁s did 𝘁𝗵𝗶𝘀 𝗴𝗿𝗼𝘂𝗽 𝗼𝗳 #𝗱𝗲𝗿𝗺𝗮𝘁𝗼𝗹𝗼𝗴𝗶𝘀𝘁𝘀 𝗮𝗴𝗿𝗲𝗲 𝗼𝗻 𝘄𝗵𝗲𝗻 𝘁𝗵𝗲 #𝗷𝗼𝗶𝗻𝘁𝘀 𝗮𝗿𝗲 𝗶𝗻𝘃𝗼𝗹𝘃𝗲𝗱?

😉 𝐘𝐨𝐮 𝐨𝐧𝐥𝐲 𝐥𝐞𝐚𝐫𝐧 𝐭𝐡𝐢𝐬 𝐬𝐭𝐮𝐟𝐟 𝐢𝐟 𝐲𝐨𝐮 𝐰𝐨𝐫𝐤 𝐚𝐥𝐨𝐧𝐠𝐬𝐢𝐝𝐞 𝐃𝐫.Rao, 𝐨𝐫, of course, 𝐢𝐟 𝐲𝐨𝐮 𝐥𝐢𝐬𝐭𝐞𝐧 𝐭𝐨 𝐭𝐡𝐞 Skin and Joints Podcast

Episode supported by Novartis Canada

📻www.skinandjoints.ca

✉️info@skinandjoints.ca

About Dr.Jaggi Rao, MD, FRCPC  

Dermatologist  | Edmonton

Dr. Jaggi Rao is a double board certified dermatologist (Canada and USA) and a certified cosmetic surgeon. He completed his  dermatology training at the University of Alberta, followed by an accredited fellowship with the American Academy of Cosmetic Surgery in Southern California. Dr. Rao is a full Clinical Professor of Medicine at the University of Alberta. 

Dr. Rao has won several accolades for research and teaching, including the Canadian Dermatology Association’s Teacher of the Year Award.

In 2011, he was the recipient of Avenue Magazine’s Top 40 under 40 Award. He has authored over 50 scientific papers and textbook chapters, and has been an invited speaker for over 500 lectures worldwide to physicians, other professionals, and the general public.

Dr. Rao continues to lend his expertise to various organizations. He sits on the board of directors for CAAM( Canadian Association of Aesthetics  Medicine) and acts as a consultant to the government (such as the Canadian Standards Association), laser and pharmaceutical industry, and professional sports teams.

About Dr.Perla Lansang, MD, FRCPC

Dermatologist  | Toronto

Dr.Perla Lansang is head of dermatology at Sunnybrook Hospital in Toronto, Ontario and is an assistant professor in the Division of Dermatology, University of Toronto.  She has a special interest in pediatric and adolescent dermatology, having done two years of fellowship in paediatric dermatology at The Hospital for Sick Children. 

At Sunnybrook, she sees general medical dermatology patients and also holds a pregnancy dermatology clinic and also has  a special focus on psoriasis, atopic dermatitis, cutaneous lymphoma, and general medical dermatology. Aside from Sunnybrook Hospital, Dr. Lansang is also affiliated with Women’s College Hospital where she runs a clinic at the Phototherapy Education and Research Centre. She also sees patients at The Hospital for Sick Children, where she has her pediatric dermatology practice.

Dr.Lansang is also a Skin and Joints Podcast Faculty expert.

RESEARCH ARTICLE discussed:

• Management of Plaque Psoriasis With Biologic Therapies in Women of Child-Bearing Potential Consensus Paper
• Jensen Yeung, Melinda J. Gooderham, Parbeer Grewal, Chih-ho Hong, Perla Lansang, Kim A. Papp, Yves Poulin, Irina Turchin, Ronald Vender

Learning Objectives 

• Discuss appropriate immunotherapy strategies for women of child bearing potential  with a focus on safety 
• Understand  practical real world clinical  implications for managing moderate to severe plaque psoriasis in women of child bearing potential (WOCBP) pre-partum, pregnancy, and post partum   as well as barriers  and opportunities for implementation 
• Implement strategies to improve multidisciplinary care coordination between primary care providers and specialty care providers and address the needs of patients 

Supported by an IME grant from UCB Canada.

www.skinandjoints.ca

A big thank you to  the thousands of healthcare providers. specialists, and primary care providers, signed up and engaged with the Skin and Joints podcast from across the country!

Episode Learning Objectives

• Discuss appropriate assessment strategies for disease activity and prognosis to guide treatment decisions for moderate to severe plaque psoriasis
• Apply current evidence and guidelines on targeted biologics with shared decision-making to make effective individualized treatment decisions for patients with moderate-to-severe plaque PsO (specifically ixekizumab and Guselkumab)
• Implement evidence-based and expert consensus strategies to improve interprofessional care coordination and address the needs of patients with comorbidities

ABOUT DR.CHRISTINA HAN, MD, FRCPC:

Dr. Christina Han is a dermatologist practicing medical and surgical dermatology in Vancouver, BC and is certified to practice in both the United States and Canada. She sees a broad range of dermatology patients, including pediatric and adults and focuses her practice on medical dermatology. Her clinical focus includes inflammatory conditions, including psoriasis, atopic dermatitis, and acne. She also teaches medical students and residents and is a Clinical Assistant Professor with the Department of Dermatology at UBC. 

Disclaimer: This is an educational podcast only and does not replace professional medical advice. Please consult your healthcare provider for any health issues.

Supported by IMEs from  Janssen and Lilly 

www.skinandjoints.ca

Jason Hook is finally here! This week, we're talking about a few Sega games including the incredibly fast, robot shooty, emerald searchy game for the ages, Sonic Adventure 2: Battle! This game was amazing and perfectly encapsulated the 2000's. Sure there have been other 3D Sonic games since, some good, some bad... but nothing will ever live up to the chaos that was Sonic Adventure 2: Battle.

Follow Region Unlocked on Twitter!

Music:
Intro- 8 Bit Go! by HeatleyBros
Various clips taken from the games
Outro- Live and Learn from the Sonic Adventure 2 soundtrack

Hello Lamer Gamers! This is simplyTravis for the Lamer Gamers Podcast! Welcome to the Xbox Beta Bonanza episode! Oh…and by the way… I’m back! I’ve been on the receiving end of a wombo combo from life in the form of a back injury and then the flu! Ain’t nobody got time for that! You may hear the occasional cough or sniffle coming from my general direction during this cast but honestly, I’m just glad to be back up and running! I’ve missed you fine folks that are scattered across the land listening to our podcast and boy do I have stuff to talk about today! 

In today’s episode I will talk about all things Beta. Now I don’t mean like the kinda beta that somebody may call you in a political internet argument, I’m talking about beta games and operating systems! I’ve recently signed up for Xbox Insider to check out if the new user interface they keep talking about is really all it’s cracked up to be then after that I’ll grab some magical playing cards to cast a fire spell as I burn through the Phantasy Star Online 2 closed beta! To finish things off I’ll sign up for a sketchy operation to modify my body because I want to join a cybernetic fight club in the Bleeding Edge beta! The match begins in 3…2…1… GO! 

Before we jump into the Xbox Insider Beta if you like the stuff we do here on the show make sure to share this podcast with a friend and hit subscribe on whatever fancy podcast player you are using! You can find out more at www.lamergamers.com/subscribe